IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...

Philips and Masimo are renewing their yearslong collaboration in patient monitoring with what they describe as an expanded focus on developing next-generation vital sign readers, plus a plan to work ...

Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...

On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.

The USITC has officially terminated the Apple Watch blood oxygen case. Discover why Apple’s 2026 workaround is here to stay ...

Apple can continue selling redesigned Apple Watches with a blood oxygen feature after the International Trade Commission ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance. Designed on ...

Masimo’s Rainbow Acoustic Monitoring sensor, RAS-125 Acoustic Respiration Cloth Sensor, was granted FDA 510(k) clearance for monitoring pediatric patients. Previously, clinicians could only use the ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. The medtech has tapped Katie Szyman for the role, who has been serving as the worldwide ...

A Previously Banned Apple Watch Health Feature May Soon Make a Comeback ...

Danaher said Tuesday it has agreed to acquire patient monitoring company Masimo for $9.9 billion to bolster its diagnostics franchise. Masimo will become a standalone business unit and brand within ...